1,2-dimethyl-1H-imidazole-4-sulfonamide → HCID 22244680, 화합물
반응식
[CH3:1][C:2]1[C:6]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)=[C:5]([CH3:13])[N:4]([C:14]2[CH:19]=[CH:18][C:17]([CH2:20][CH2:21][NH:22][C:23](=O)[O:24]C3C=CC=CC=3)=[CH:16][CH:15]=2)[N:3]=1.[CH3:32][N:33]1[CH:37]=[C:36]([S:38]([NH2:41])(=[O:40])=[O:39])[N:35]=[C:34]1[CH3:42]>>[CH3:1][C:2]1[C:6]([C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][CH:12]=2)=[C:5]([CH3:13])[N:4]([C:14]2[CH:15]=[CH:16][C:17]([CH2:20][CH2:21][NH:22][C:23]([NH:41][S:38]([C:36]3[N:35]=[C:34]([CH3:42])[N:33]([CH3:32])[CH:37]=3)(=[O:40])=[O:39])=[O:24])=[CH:18][CH:19]=2)[N:3]=1참가 물질
3
실험 절차
The title compound was prepared according to the procedure described in step 2 of Example 22 from phenyl 2-[4-(3,5-dimethyl-4-phenyl-1H-pyrazol-1-yl)phenyl]ethylcarbamate (step 1 of Example 22) and 1,2-dimethyl-1H-imidazole-4-sulfonamide: 1H-NMR (CDCl3) δ 7.50-7.27 (10H, m), 3.62 (3H, s), 3.46-3.41 (2H, m), 2.87-2.82 (2H, m), 2.37 (3H, s), 2.32 (3H, s), 2.27 (3H, s).
출처 및 근거
- ORD 기록
- ord-55fc6a26f3474a3cb98e55837d333f26
- 출처 데이터셋
- uspto-grants-2006_02